Using a blood test to better diagnose bipolar disorder
Part of Mental health clinical trials.
This trial tests a new medical device that uses a blood test to help doctors accurately diagnose bipolar disorder in people who were thought to have major depression. It aims to see if the device can tell the difference and improve treatment choices.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have been diagnosed with moderate to severe major depression and are eligible for antidepressant medication
- You have not taken any psychiatric medication in the last 5 days (or 21 days for specific drugs like fluoxetine or aripiprazole), except for some sleep aids or anti-anxiety medications
- You do not have schizophrenia, an unstable medical condition, or an autoimmune disease like Crohn's or thyroiditis
- You are not pregnant or breastfeeding, and you can read and understand French
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to deliver lithium, a common treatment for bipolar disorder, using tiny gold particles. It aims to see if this method is safe and effective in laboratory models, which may lead to better treatments with fewer side effects.
This study uses smartphone and smartwatch data, along with biological samples, to find markers that might improve diagnosis and predict mood episodes in bipolar disorder. It may help develop better monitoring tools for mood conditions.
This trial tests a non-invasive light therapy called transcranial photobiomodulation, which uses red or near-infrared light to stimulate brain cells. It may help relieve symptoms of bipolar depression without medication side effects.
This study looks for biological markers in the blood or spinal fluid that might predict how well a new psychiatric treatment will work. If you have a psychiatric condition that hasn't improved with previous treatments, this research could help find better ways to match treatments to individuals in the future.
This study checks how much lithium is naturally present in the blood and whether that relates to suicidal thoughts or attempts in people with a current major depressive episode. It may help researchers understand biological factors linked to suicide risk and improve future prevention.
This study tests a new blood test (EDIT-B®) to help doctors tell the difference between depression and bipolar disorder. If you have a depressive episode but there is doubt about bipolar disorder, this test might help guide your treatment to improve your health.
Hear when a new Primary Care trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.